Trial Information

Summary: ECOG E5597 "Phase III chemoprevention trial of selenium supplementation in persons with resected stage I non-small cell lung cancer Patients who have undergone complete resection of a histologically proven stage IA(pT1N0) or stage IB(pT2N0)non-small cell lung cancer

Selenium is an "essential trace element," meaning that it is a naturally-ocurring substance required for normal, healthy functioning. Selenium reduces certain kinds of tumors in animals and enhances immune properties in humans. Recent nutrition intervention trials support the idea that selenium may reduce the risk of cancer in some instances. This is why this study has been developed.

Patient Inclusion Criteria

• People who had surgery for stage I non-smll cell lung cancer in the past three years

Patient Exclusion Criteria

• People who have had chemotherapy or radiation therapy

For more information,

If you would like to learn more about participating in this study, please send an e-mail message using the form below.